Success Story: We Helped an Indian Postdoctoral Research Fellow Win NIW Approval Fast with Premium Processing

Posted by wegreened on January 30, 2026 in Cancer Biology, NIW

Client’s Testimonial:

“I wanted to take a moment to express my sincere gratitude for your exceptional handling of my I-140 case. Your approach was impressively organized, and you consistently responded in a timely manner. Every detail of my case was prepared meticulously, and you addressed all my doubts with clear, concise explanations. Overall, I’m truly impressed with your professionalism and efficiency in managing my case. Thank you for your outstanding support.”

On April 1^st, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Fellow in the Field of Cancer Biology (Approval Notice).

General Field: Cancer Biology

Position at the Time of Case Filing: Postdoctoral Research Fellow

Country of Origin: India

State of Residence at the Time of Filing: Missouri

Approval Notice Date: April 1^st, 2025

Processing Time: 1 month, 19 days (Premium Processing Requested)

Case Summary:

We are proud to share the successful I-140 NIW approval of an Indian Ph.D. holder whose work is focused on addressing one of the most persistent challenges in modern oncology: drug resistance in cancer therapy. Her proposed endeavor aims to identify novel therapeutic targets to improve personalized medicine and enhance treatment outcomes for cancer patients.

Currently conducting research in the United States, the client’s work has broad implications for both public health and healthcare cost reduction. Her innovative approaches integrate synthetic biology, protein engineering, and tumor signaling analysis to develop optimized drug delivery methods and overcome the barriers posed by multidrug resistance.

To support her petition under the National Interest Waiver (NIW) category, we highlighted:

12 peer-reviewed journal articles, including 11 first-authored papers, plus 1 edited book, 3 book chapters, and 1 preprint;
248 citations, with three papers ranked among the top 10% and one among the top 20% most cited in clinical medicine for their publication years;
Peer review contributions, national media coverage, and multiple research awards in recognition of her influence.

Her findings on plant-derived compounds and apoptosis-inducing agents have been adopted by other researchers and cited in studies developing anti-cancer therapies and drug discovery pipelines. Her work has been featured in widely circulated media outlets and supported by major academic institutions and funding sources.

With a strong record of innovation and impact, the client was found to be exceptionally well-positioned to continue advancing her research in the U.S. Her petition was approved after 1 month and 19 days via direct premium processing, further underscoring the strength of her case.

We congratulate her on this significant milestone and look forward to her continued contributions to the future of cancer therapeutics.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2020.01 - 2024.12)

Category	Approval or Refund^®		Approval or Refiling^TM
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	28,946	99.52%	3,030	98.31%
EB1A	4,322	91.76%	2,870	88.91%
EB1B	793	98.51%	236	90.77%
Total	34,061	98.44%	6,136	93.39%